Neurology deals with diagnosis and treatment of disease conditions of central and peripheral nervous system and is one of the typical disciplines where personalized medicine has becoming an important part of clinical trials. Different issues in neurology are to be discussed in relation to personalized medicine and diagnostic, prognostic and predictive blood biomarkers.
The role of biomarkers & personalized medicine in neuro-oncology is becoming extensively important. The actual state of knowledge in several domains of neurology (neuro-oncology, cerebrovascular, neurodegenerative, and demyelinating diseases) are to be discussed.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: American Neurological Association (ANA), North American Neuromodulation Society, European Academy of Neurology, American Board of Psychiatry and Neurology, ALS society of Canada, International society for oncology.